Billionaires Holding ORPN

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 13.0M
    Shares Outstanding

  • 77.3M
    Market Cap

News & Insights

ABOUT

ORPN

Bio Blast Pharma Ltd., a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases. Its products include Cabaletta, a mutant protein stabilizing platform based on a small repurposed molecule to treat oculopharyngeal muscular dystrophy, Machado...

Hedge funds hate Apple ... but love Facebook

NEWS

BRIEF-Berkshire Hathaway buys about 824,000 shares of Phillips 66

READ MORE